Primary allergic sensitization to environmental antigens: perinatal T cell priming as a determinant of responder phenotype in adulthood
Related Experiment Videos
1Division of Cell Biology, TVW Telethon Institute for Child Health Research, West Perth, Western Australia.
The Journal of Experimental Medicine
|April 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.
Clinical and experimental immunology·2016
Childhood atopy and mental health: a prospective, longitudinal investigation.
Psychological medicine·2016
Relationship between cytokine expression patterns and clinical outcomes: two population-based birth cohorts.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Cbfβ regulates DNA looping at the Il4-Il13 loci to control their differential expression in Th2 cells.
The Journal of experimental medicine·2026
Alzheimer's genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis.
The Journal of experimental medicine·2026
Vanin-pantethine metabolic axis shapes dendritic cell function and affects inflammatory disorder progression.
The Journal of experimental medicine·2026
Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses.
The Journal of experimental medicine·2026
Antigen-independent BCR signals limit differentiation and survival of IgM antibody-secreting cells.
The Journal of experimental medicine·2026
Parkinson's at the brain border.
The Journal of experimental medicine·2026
Recurrent Reactions to Enzyme Replacement Therapy in Infantile-Onset Pompe Disease: A Case of Immunologic Barriers to Drug Tolerance.
American journal of medical genetics. Part A·2026
52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study.
Journal of the American Academy of Dermatology·2026